ClinicalTrials.Veeva

Menu

Assessment and Rehabilitation of Cognitive Impairments in Pediatric Survivors of Cancer

Stanford University logo

Stanford University

Status

Completed

Conditions

Neoplasms

Study type

Observational

Funder types

Other

Identifiers

NCT00490334
PEDSVAR0003 (Other Identifier)
IRB-08123
97817 (Other Identifier)

Details and patient eligibility

About

This research involves assessment of cognitive outcome in childhood cancer as well as evaluation of a cognitive rehabilitation program for improving learning and problem solving difficulties in children with cancer.

Full description

The purpose of this study is to help determine specific cognitive-behavioral and neurobiologic impairments associated with chemotherapy treatments in children with cancer and to assess the efficacy of a cognitive intervention program for improving cognitive impairments in these children.

Enrollment

72 patients

Sex

All

Ages

9 to 16 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

INCLUSION

Everyone:

  • At least 9 years of age and less than 17 years

Patients

  • Diagnosis of brain tumor or acute lymphocytic leukemia (ALL)
  • Completed all anti-cancer treatment(s) including chemotherapy, radiation and/or surgery

Control group

  • Typical for age

EXCLUSION

Everyone:

  • Non-English speaking (translated cognitive testing and MRI assessments unavailable)
  • MRI contraindication, including but not limited to orthodontia, metal implants, and/or pacemaker
  • Major sensory deficit disorders, including but not limited to blindness or deafness

Patients

  • Shunt placement
  • Received bone marrow transplant
  • History of neurologic, psychiatric, developmental or major medical condition (eg, diabetes) NOT related to cancer
  • Participation in any concurrent cognitive rehabilitation study

Control group

  • History of neurologic, psychiatric, developmental or major medical condition (eg, diabetes)

Trial design

72 participants in 2 patient groups

Cancer patients
Description:
Children with cancer aged 8 to 16 years
Control (non-cancer)
Description:
Normal children aged 8 to 16 years, age- and gender-matched to the cancer cohort

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems